DFX Intelligence

Data Factory

Mercy Bio

We are making early-stage cancer easier to find using extracellular vesicles found in blood, specific to their parent cells.

This is the graph view. The full profile, with its team, deals and sources, is on Venture Capital.Open the full profile →

Search this name across graphsid dfx:vc:496ff7fc-6172-4d31-81c1-a163e1b7c032

Data as of Sep 19, 2026 (this record's last observation) from Sworn filings; Announcements; Limited partners. Page built Sep 19, 2026, 5:06 PM UTC and rebuilt at most every 15 minutes.

Relationships: 2
Dated events: 0
On other graphs: 0
Observed: Sep 12, 2026 to Sep 19, 2026
7 observations

Across DFX

This entity has not been resolved onto another DFX graph by a shared identifier. A name match elsewhere would be a candidate, never an identity, and none is recorded.

Facts

fact = as filed or announced; derived = computed by DFX; estimate = a band, never a point

Rounds: 0
Investors: 2
People: 0
Website: mercybio.com

Investors

Investor	Class	Fund	Partner	Role	Attribution
Iselect Fund Management, LLC	Institutional VC	n/a	n/a	unknown	Unknown
Portfolia Venture Management, LLC	Institutional VC	n/a	n/a	unknown	Unknown

Relationships

Invested in (2)

← Iselect Fund Management, LLCFirmPortfolio listing
Sep 16, 2026 to presentfactThe subject's own site
← Portfolia Venture Management, LLCFirmPortfolio listing
Sep 16, 2026 to presentfactThe subject's own site

Dated events

No dated event names this entity yet.

Provenance

Graph: Venture Capital
Canonical id: dfx:vc:496ff7fc-6172-4d31-81c1-a163e1b7c032
First observed: Sep 12, 2026
Last observed: Sep 19, 2026 13 h ago
Resolution: Identity across graphs by shared identifier (CRD, CIK, EIN, ADV fund id, individual CRD) or citation; a name match is shown as a candidate and never merged.